- |||||||||| Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment closed, Enrollment change: Cimzia Versus Mesalamine for Crohn's Recurrence (clinicaltrials.gov) - Mar 17, 2016 P4, N=10, Active, not recruiting, Trial primary completion date: Feb 2016 --> Oct 2017 Recruiting --> Active, not recruiting | N=24 --> 10
- |||||||||| Trial completion, Enrollment change, Tumor cell: Circulating Tumor Cells in Operative Blood (clinicaltrials.gov) - Feb 24, 2016
P=N/A, N=3, Completed, Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed | N=20 --> 3
- |||||||||| Votrient (pazopanib) / Novartis, BeiGene
Biomarker: Neoadjuvant Pazopanib in Renal Cell Carcinoma (clinicaltrials.gov) - Jan 20, 2016 P2, N=21, Active, not recruiting, Completed --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Jan 2017 Recruiting --> Active, not recruiting | N=56 --> 21
- |||||||||| Trial primary completion date: FACBC for Recurrent Prostate Cancer (clinicaltrials.gov) - Jan 19, 2016
P2, N=25, Active, not recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Oct 2016
- |||||||||| Civacir (hepatitis C immune globulin) / ADMA Biologics, Kedrion
Enrollment closed, Trial primary completion date: Civacir (clinicaltrials.gov) - Jan 19, 2016 P3, N=80, Active, not recruiting, Trial primary completion date: Dec 2015 --> Oct 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Feb 2016
- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Enrollment closed, Enrollment change, Trial primary completion date: Rituximab to Prevent Recurrence of Proteinuria (clinicaltrials.gov) - Jan 16, 2016 P3, N=43, Active, not recruiting, Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting | N=60 --> 43 | Trial primary completion date: Feb 2016 --> Feb 2017
- |||||||||| Enrollment closed, Metastases: Non-Interventional Study PREVENT (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=200, Active, not recruiting, Recruiting --> Active, not recruiting | N=60 --> 43 | Trial primary completion date: Feb 2016 --> Feb 2017 Recruiting --> Active, not recruiting
- |||||||||| Enrollment change, Trial initiation date, Trial termination, Trial primary completion date, Tumor cell, Metastases: Prognostic Value of CTC in HNSCC Patients (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=53, Terminated, Active, not recruiting --> Completed N=300 --> 53 | Initiation date: Oct 2011 --> Jun 2012 | Recruiting --> Terminated | Trial primary completion date: Oct 2014 --> May 2015; participants are no longer being examined or treated
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Mucosal Versus Fecal Microbiota in FMT (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=10, Completed, N=300 --> 53 | Initiation date: Oct 2011 --> Jun 2012 | Recruiting --> Terminated | Trial primary completion date: Oct 2014 --> May 2015; participants are no longer being examined or treated Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Jul 2016 --> Aug 2015
|